Literature DB >> 35020930

Body imaging for newly diagnosed CNS lymphoma: Evaluating the utility of the evaluation.

Julie J Miller1, Nancy Wang1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35020930      PMCID： PMC8917389          DOI： 10.1093/neuonc/noab305

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

Authors:  Lauren E Abrey; Tracy T Batchelor; Andrés J M Ferreri; Mary Gospodarowicz; Elisa J Pulczynski; Emanuele Zucca; Justine R Smith; Agnieszka Korfel; Carole Soussain; Lisa M DeAngelis; Edward A Neuwelt; Brian Patrick O'Neill; Eckhard Thiel; Tamara Shenkier; Fransesc Graus; Martin van den Bent; John F Seymour; Philip Poortmans; James O Armitage; Franco Cavalli
Journal:  J Clin Oncol       Date:  2005-06-13       Impact factor: 44.544

Review 2.  Diagnosis and treatment of primary central nervous system lymphoma.

Authors:  Igor T Gavrilovic; Lauren E Abrey
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

Review 3.  Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.

Authors:  Khê Hoang-Xuan; Eric Bessell; Jacoline Bromberg; Andreas F Hottinger; Matthias Preusser; Roberta Rudà; Uwe Schlegel; Tali Siegal; Carole Soussain; Ufuk Abacioglu; Nathalie Cassoux; Martina Deckert; Clemens M F Dirven; Andrés J M Ferreri; Francesc Graus; Roger Henriksson; Ulrich Herrlinger; Martin Taphoorn; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2015-07       Impact factor: 41.316

4.  Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.

Authors:  Christian Grommes; James L Rubenstein; Lisa M DeAngelis; Andres J M Ferreri; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

5.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

6.  Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma.

Authors:  Chong Hyun Suh; Ho Sung Kim; Sung Soo Ahn; Minjung Seong; Kichang Han; Ji Eun Park; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim; Sang Min Lee; Jeong Hoon Kim; Seung-Koo Lee; Seung Hong Choi; Sung Tae Kim; Lakshmi Nayak; Tracy T Batchelor; Raymond Y Huang; Jeffrey P Guenette
Journal:  Neuro Oncol       Date:  2022-03-12       Impact factor: 13.029

7.  Diagnostic Yield of Body CT and Whole-Body FDG PET/CT for Initial Systemic Staging in Patients With Suspected Primary CNS Lymphoma: A Systematic Review and Meta-Analysis.

Authors:  Ho Young Park; Chong Hyun Suh; Raymond Y Huang; Jeffrey P Guenette; Ho Sung Kim
Journal:  AJR Am J Roentgenol       Date:  2020-08-19       Impact factor: 3.959
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.